HOME >> BIOLOGY >> NEWS
Actonel significantly reduced moderate and severe vertebral fractures

San Antonio, TX (September 20, 2002) A new analysis of scientific data presented at today's meeting of the American Society for Bone and Mineral Research (ASBMR) showed that a 5 mg dose of Actonel (risedronate sodium tablets) daily significantly reduced moderate and severe vertebral fracture risk by 70 percent within one year in postmenopausal women with osteoporosis. Furthermore, the significant effect on vertebral fracture risk was sustained over three years.

This analysis combined data from two large Actonel clinical trials, VERT-NA and VERT-MN, which included postmenopausal women with either one prevalent vertebral fracture and low bone mineral density (BMD), or with at least two prevalent vertebral fractures. The objective of this analysis was to compare the incidence of moderate or severe vertebral fracture at one year in women who received Actonel or placebo. Fracture severity was determined using the fracture severity scoring system developed by Harry Genant, M.D., Professor of Radiology, Medicine, Epidemiology and Orthopaedic Surgery at the University of California, San Francisco, an investigator and pioneer of the assessment method used in the analysis.

Recent studies show severity of prevalent vertebral fractures is a predictor of future vertebral and non-vertebral fracture risk; patients with more severe baseline vertebral fractures are more likely to experience subsequent vertebral and non-vertebral fractures. Therefore, reducing the incidence of moderate or severe vertebral fractures may help decrease the risk of future fractures.

"The ultimate goal of osteoporosis treatment is to prevent fractures," said Dr. Genant, "These new findings, combined with previous Actonel clinical data showing reductions in both risk of first vertebral fracture and multiple vertebral fractures, suggest that Actonel reduces fracture risk across a range of osteoporotic severity."

According to
'"/>


20-Sep-2002


Page: 1 2 3 4

Related biology news :

1. Rare mutations can significantly increase risk factor for heart disease
2. Cancer health risk significantly underestimated by EPAs ambient model estimates
3. Double mastectomies significantly lower risk of breast cancer in women who are genetically at risk
4. HAART therapy significantly prolongs survival in AIDS patients with central nervous system lymphoma
5. ENBREL rapidly, significantly improved back pain, mobility, function in ankylosing spondylitis
6. Once weekly ENBREL significantly reduced rheumatoid arthritis pain, inflammation & improved function
7. Cognitive abilities increase significantly with time in most prematurely born children
8. Combining key ingredients of vegetarian diet cuts cholesterol significantly, says study
9. Pollen productionand allergiesmay rise significantly over next 50 years
10. Brain size in premature infants significantly smaller than full-term babies
11. Multicenter study shows Benecol spread significantly reduces cholesterol levels in patients taking statin drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/1/2018)... ... October 01, 2018 , ... ... the nation’s elderly, stories surrounding such facilities are dire. Lawsuits dot the ... provider, which alleges that the chain’s “callous and profit-driven approach” has had “devastating” ...
(Date:9/29/2018)... Calif. (PRWEB) , ... September 29, 2018 , ... ... to chief officers of Life Science companies. The in-person briefings are expected to ... that data science is bringing to the U.S. healthcare market—especially to individuals, employers, ...
(Date:9/28/2018)... ... September 28, 2018 , ... Purification , The fluorescent-dye labeled bacmid DNA must ... Purification Kit. Samples were gently mixed with 275 µL of provided PB buffer (Qiagen), ... at room temperature. Flow-through was discarded and 750 µL of provided PE buffer (Qiagen) ...
Breaking Biology News(10 mins):
(Date:10/2/2018)... ... October 02, 2018 , ... ... Bio-Energy Solutions™, LLC’s (Locus Bio-Energy) AssurEOR product line was chosen for its advancements ... Gulf Energy Information, honor leading innovations in upstream oil applications that are positively ...
(Date:10/2/2018)... ... October 02, 2018 , ... The Alliance ... teams have initiated validation of standards and testing of procedures for voluntary accreditation ... Larry Kennedy, ACRES VP for Quality Management Systems and Chief Quality Officer, is ...
(Date:9/28/2018)... ... September 28, 2018 , ... GlycoMark®, Inc. has announced ... the GlycoMark test, the only FDA-cleared blood test specific to detecting recent hyperglycemia ... and offer the GlycoMark test to its network of physicians through its sales ...
(Date:9/27/2018)... , ... September 26, 2018 , ... ... Dr. B. Melina Cimler, a senior quality, regulatory, and in vitro diagnostic device ... FDA-regulated global diagnostic industry has joined the firm as an Expert Consultant. Her ...
Breaking Biology Technology:
Cached News: